Globe Life is considered about 4.8% undervalued following its mixed second-quarter 2026 earnings, with a fair value estimate of $190.09 per share versus a recent close of $181. The company's earnings beat was offset by weaker sales trends and softer underwriting margins, while an expanded US$2.5 billion buyback authorization and a planned Bermuda reinsurance affiliate are expected to boost free cash flow and earnings per share by 2027. The stock has returned 16.74% over the past 90 days and 34.73% over the past year, and its current price-to-earnings ratio of 11.5 times is nearly in line with the US insurance sector average of 11.5 times.
Globe Life IncMixed Q2 earnings: beat offset by weaker sales and margins, plus buyback and Bermuda affiliate expected to boost EPS by 2027.
